Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for ...

U.S. healthcare organizations lose $1.9 million on average during each day of downtime following a ransomware attack, ...

Walgreens is reportedly exploring selling itself to private equity firm Sycamore Partners. It might be the right decision for ...

Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare ...

The modern concept of “triage” dates to the Napoleonic Wars, when French battlefield surgeons developed a system for assessing the wounded and determining treatment priority to govern ...

Ascension’s May cyberattack compromised 5.6 million patients’ personal and health information, including Social Security numbers, credit card numbers and addresses. However, there is no evidence that ...

Agitation caused by Alzheimer’s disease currently has one FDA-approved therapy, but that drug brings serious safety risks. An Axsome Therapeutics drug has mixed results from its latest slate of ...

Cardiologist and researcher Dr. Eric Topol is considered by many to be one of the leading voices contributing to the conversation around technology’s impact on healthcare. Dr. Topol — who has ...

In the patient payments space – just like healthcare information technology, in general – change happens at an accelerated pace. Across the healthcare industry, we are witnessing a rapid shift ...